==== Front AIMS Public Health AIMS Public Health PublicHealth AIMS Public Health 2327-8994 AIMS Press publichealth-07-04-061 10.3934/publichealth.2020061 Research Article Vitamin D deficiency is not related to eating habits in children with Autistic Spectrum Disorder Riccio Maria Pia 1 Catone Gennaro 2 Siracusano Rosamaria 1* Occhiati Luisa 3 Bernardo Pia 4 Sarnataro Emilia 1 Corrado Giuseppina 1 Bravaccio Carmela 1 1 Department of Translational Medical Science, Child and Adolescent Neuropsychiatry, University Federico II of Naples, Italy 2 Department of Educational, Psychological and Communication Sciences. Suor Orsola Benincasa University, Italy 3 Department of Translational Medical Science, Section of Pediatrics, University Federico II of Naples, Italy 4 Department of Pediatric Neurosciences, Unit of Neuropsychiatry, Santobono-Pausilipon Children's Hospital, Naples, Italy * Correspondence: Email: rosamaria.siracusano@unina.it; Tel: +390817463398. 15 10 2020 2020 7 4 792 803 12 9 2020 9 10 2020 © 2020 the Author(s), licensee AIMS Press2020the Author(s)This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)Background and aims Autism Spectrum Disorder (ASD) is characterized by the impairment of communication and social interaction and by repetitive, restricted and stereotyped interests. ASD is often accompanied by comorbidities; eating disorders are frequent and imply important nutritional deficits (i.e. deficiencies of vitamins, minerals and fatty acids). Vitamin D has a critical role in neurodevelopment and serum levels in ASD are reported inadequate. A useful reference for setting up a correct diet in childhood is the food pyramid, which is inspired by the Mediterranean Diet (MD). The MD guarantees an intake of nutrients, considered optimal to maintain an adequate nutritional status. The aim of this study is to explore serum levels of Vitamin D and food habits (through MD adherence) in a sample of children with ASD and evaluate a possible correlation between these factors. Methods study participants include 91 children 47 presenting ASD and 44 healthy typically-developing (TD) subjects, as control group. We evaluated serum level of Vitamin D in both group; anthropometric parameters (weight, height, body mass index—BMI—and growth percentile) and MD adherence have been explored, in order to investigate the correlation among those data and level of Vitamin D in children with ASD. Lastly, the association between Vitamin D levels and severity of ASD symptoms has been analysed. Results and conclusion 74% of ASD group presented blood levels of Vitamin D under 30 ng/ml (normal range 30–100 ng/ml). The analysis performed showed that the two groups were significant different regards Vitamin D levels (t = 2.24, p < 0.05), according to literature. 31.9% of children with ASD presented a condition of overweight and 12.6% a condition of obesity. Adherence to the MD was low in 25.5% of cases. No significant statistical correlation has been found between Vitamin D serum levels, anthropometric parameters and the adherence to MD in the ASD group. Autism Spectrum Disordereating habitsnutritional status25 hydroxy vitamin Dvitamin D deficiencyAbbreviations ASDAutism Spectrum Disorder DSMDiagnostic and Statistical Manual of Mental Disorders TDTypically-developing DBPVitamin D Binding Protein VDRVitamin D receptor MDMediterranean Diet UNESCOUnited Nations Educational Scientific and Cultural Organization ADOS-2Autism Diagnostic Observation Schedule-2 GMDS-ERGriffiths Mental Development Scale-Revised VABS-IIVineland Adaptive Behavior Scales-II edition SPSS-25th ed.Statistical Package for Social Sciences software 25th edition IDIntellectual Disability BMIBody Mass Index ==== Body 1. Introduction Autism Spectrum Disorder (ASD) is a developmental disorder which affects communication and behavior, characterized by impairment of communication and social interaction and by repetitive, restricted and stereotyped interests [1]. There are several comorbidities associated with ASD, both psychiatric and medical. Among the latter, a condition frequently associated are eating disorders, especially regarding food selectivity which may affect up to 70–80% of ASD children [2]. Food selectivity has been accurately defined by Bandini et al. [3], who reported that ASD children exhibit more food refusal and limited food repertoire than tipically-developing (TD) children. Moreover, in ASD food selectivity persists throughout childhood and the food repertoire remains narrowed [4]. Children with ASD eat a narrower range of food than TD children [5] and often they made food choices based on texture [6]. Proposed factors influencing food refusal are mainly related to the characteristics of food and they can be at least partially explained by bitter taste sensitivity [7]. Food refusal is often accompanied by important nutritional deficits that can also cause serious health problems. In detail, children with ASD frequently have deficiencies of vitamins, minerals and fatty acids. Using a prospective dietary data to study children with ASD, Edmond et al. observed that they eat less salad, fruits and in general less vegetables [8]. Bandini et al. found that children with ASD had inadequate intake of nutrients comparing to TD children with same age [3]. This poor supply can lead to lower concentrations of Vitamin A, Vitamin C, Folic Acid, biotin, calcium, zinc and iron in children with ASD [9]. In addition, serum concentration of pantothenic acid, vitamin B12, Vitamin E and Vitamin D have been found to be lower in ASD participants; in particular, levels of Vitamin D are significant lower compared to their peers [10]. Vitamin D is a fat-soluble vitamin existing in nature in the form of ergocalciferol (D2) and cholecalciferol (D3); it is converted to an active form in the liver and kidney. Vitamin D metabolites circulate in the blood linked to Vitamin D Binding Protein (DBP). Its action is mediated by the vitamin D receptor (VDR), a nuclear receptor expressed in over 30 different tissues. The recommended level of Vitamin D in both adults and children should be at least above 30 ng/ml [11]. The best available vitamin D sources in food are cod liver oil and fatty fish. In addition, mushrooms, fish, eggs, meat, and dairy products contain Vitamin D2 and D3 [12]. Vitamin D play a critical role in neurodevelopment, especially related to brain cell growth and differentiation and several works in literature have explored its role in the ASD etiology [13]. A wide variety of foods in the diet minimises the possible deficiency of a particular nutrient. The Mediterranean Diet (MD), considered as an Intangible Cultural Heritage of Humanity by United Nations Educational Scientific and Cultural Organization (UNESCO) in 2010, is a dietary pattern rich in plant foods, along with high to moderate intakes of fish and seafood, moderate consumption of eggs, poultry and dairy products, low consumption of red meat and a moderate intake of alcohol. MD ameliorates the intakes of micronutrients and is associated with better health effects. The present study aims to explore serum levels of Vitamin D in children with ASD comparing to a control group of TD subjects. Nutritional status (auxological parameters) and eating habits (MD adherence), are also evaluated in order to investigate their relationship with Vitamin D levels in children with ASD. Lastly, we investigate the association between Vitamin D levels and ASD severity symptoms. 2. Methods 2.1. Subjects Participants were a consecutive sample of children, along 12 months, referred to Department of Pediatrics—Unit of Child and Adolescent Neuropsychiatry, University Federico II of Naples, for an evaluation in a clinical suspicion of ASD. About 160 children received a full assessment, including historical informations (pregnancy, childbirth, birth weight, breastfeeding, weaning), structured clinical interviews and validated observations. Autism Diagnostic Observation Schedule-2 (ADOS-2) [14] was performed by a licensed clinician both to confirm diagnosis and to evaluate level of symptoms according to comparative score. To determine the development/intellective level, Griffiths Mental Development Scale (GMDS-ER) [15] or Leiter International Performance Test-Revised (Leiter-R) [16] were administered. To establish adaptive competence of all participants with ASD, parents were interviewed by Vineland Adaptive Behavior Scales—II edition (VABS-II) [17]. Diagnosis of ASD was formulated according to DSM-5th Edition [1], and through a period of 12 months, almost 100 children received a diagnosis of ASD. The study was conducted in according to principles of Helsinki Declaration; ethical approval was obtained by the Ethics Committee of the University Federico II of Naples. Written informed consent was collected from parents or legal guardians of enrolled children for both clinical information collection and data acquisition and treatment. Study participants included 91 children of which 47 had a diagnosis of ASD, whose parents signed informed consent form to participate to the study. Children were aged between 24 and 132 months (Mean age = 47.3 months; S.D. ± 15.38), and were both male (n = 33) and female (n = 14). According to DSM-5 criteria, clinical severity level was distributed as follows: 19.1% of cases were categorized as “Level 1” severity, that refers to clinical conditions in which a subject needs a support to have an adequate adaptation; 36.2% as “Level 2” severity, that refers to clinical conditions in which a subject needs a significant support to have an adequate adaptation; finally, 44.7% as “Level 3” severity, that refers to clinical conditions in which a subject needs a very significant support to have an adequate adaptation. According to the criteria of the DSM-5, other specifiers of the diagnosis were distributed as follows: 83% of cases presented ASD “With accompanying language impairment” (no intelligible speech, single words or isolated sentences); 61.7% presented ASD “With accompanying intellectual impairment” (according to results of developmental/intellectual/adaptive level, evaluated through GMSD-ER, Leiter-R and VABS-II). Detailed clinical features of ASD sample are described in Table 1. Inclusion criteria were a clinical diagnosis of ASD, age between 24 and 132 months; exclusion criteria included: advanced pubertal growth; epilepsy diagnosis or other neurological disorders; other chronic diseases (e.g. chronic intestinal diseases, malabsorption, etc.); major malformations or previous gastroenteric, urinary or respiratory surgery. 44 healthy TD subjects, aged between 24 and 132 months (Mean age = 65.23 months; S.D. ± 22.6) both males (n = 25) and females (n = 19), were recruited as control group, from those who attend daily minor surgery procedures (e.g. inguinal hernia, phimosis). Inclusion criteria were the absence of psychiatric diagnosis, age between 24 and 132 months. For the control group the same exclusion criteria were used. Table 1. Clinical features of ASD Children. ASD (N = 47) Male 33 (70.2) † Age, months 47.3 (15.3) ** Autism Severity index (according DSM-5 severity levels) Low 9 (19.1) † Mild 17 (36.2) † Severe 21 (44.7) † Verbal impairment (considering verbal as producing 5 or more worlds) Children without verbal impairment 8 (17) † Children with verbal impairment 39 (83) † Intellectual impairment (IQ/DQ < 70) Children without intellectual impairment 29 (61.7) † Children with intellectual impairment 18 (38.3) † ADOS-2, Mean Total score 18.5 (5.2) ** ADOS-2 (level of symptoms according comparative score) Low level 16 (34) † Moderate level 21 (44.7) † High level 10 (21.3) † Note: ASD, Autism Spectrum Disorder; N., number; DSM-5, Diagnostic and Statistical Manual of Mental Disorders-5th Edition; IQ, Intellectual Quotient; DQ, Developmental Quotient; ADOS-2, Autism Diagnostic Observation Schedule-2. † Expressed as number of patients or controls and percentage in parenthesis; ** Expressed as Mean and Standard Deviation in parenthesis All subjects were recruited from the same geographic area (Mediterranean coast of Campania region—Southern Italy), and were Caucasian from middle socioeconomic status. 2.2. Nutritional state assessment Children were evaluated in a multidisciplinary setting (paediatrician, child psychiatrist, dietician). A dedicated module was created for collecting demographic and anamnestic data, current feeding informations (including those on special diets), clinical characteristics. Anthropometric parameters (weight, height, body mass index—BMI—and growth percentile) were collected; eating habits were evaluated through dietary diary (performed for 3 days) and adherence to the MD. The 3 days food diary consists in a collection of information regarding the type and quantity of food, drinks, condiments and supplements taken during the day (breakfast, lunch, dinner and snacks). Adherence to the MD was evaluated through KIDMED test (Mediterranean Diet Quality Index for children and adolescents) and KIDMED index was used to assess level of adherence [18]. The index ranges from 0 to 12 and is based on a 16-question test that can be self-administered or conducted by an interview. The sums of the values of the administered test are classified into three levels of score: (1) >8, optimal adherence to the MD (high adherence); (2) between 4–7, improvement necessary to adapt nutrition to the MD (moderate adherence); (3) ≤3, very low quality of adherence to the MD (low adherence). Each patient was also investigated by blood samples, also for assessment of serum 25-hydroxyvitamin D [25(OH)D] concentration. Blood samples were collected in hospital for both ASD and TD children. Phlebotomy was conducted by a pediatric nurse, collection was made in fasting status, in the morning before breakfast. All samples were regularly sent for analisis to the university central laboratory, based on gold standard reference measurement procedures and certified reference materials. Serum levels of Vitamin D (tested through direct immunoassay by chemiluminescence) were classified as follow: deficient when <10 ng/ml; insufficient between 10–30 ng/ml; and normal between 30–100 ng/ml. BMI was performed to classify children in four categories as follow [19]: underweight (< 5th percentile), normal range (between 50th and 85th percentile), overweight (between 85th and 95th percentile) and obese (>95th percentile). Aged within 24 and 36 months children were evaluated performing weight and height ratio and checking it on growth curve. 2.3. Statistical analysis We applied The Statistical Package for Social Sciences software 25th edition (SPSS-25th ed.) to perform statistical analysis. Descriptive statistics (frequencies, percentages, mean and standard deviations) were used to describe the sample. An independent sample T-Test analysis was performed in order to compare auxological parameters and the level of Vitamin D between the ASD group and the control group. A chi-square test was used to compare categorical data (BMI categories, serum level of Vitamin D as categories). Bivariate correlational analysis (Spearman coefficient) was carried out to evaluate the relationship between severity of autistic symptoms, presence of intellectual impairment, verbal impairment and vitamin D values; adherence to the MD and vitamin D values. 3. Results The groups consisted of 91 children, 47 ASD and 44 TD participants. No one was on special diet or took supplements on time of enrollment both in ASD children and in TD subjects.The main auxological and nutritional characteristics of the samples are reported in Table 2. Evaluation of BMI showed that 15/47 (31.9%) children with ASD presented a condition of overweight and 6/47 (12.8%) a condition of obesity. Only 2/47 (4.3%) children presented a condition of underweight. Whereas the control group, 4/44 (9.1%) subjects presented a condition of overweight, but there was none condition of obesity. Instead, 6/44 (13.6%) of TD children presented a condition of underweight. Comparing mean BMI value and frequencies distribution of BMI categories, the analysis revealed a significant difference between the two groups (p < 0.01). 29/47 (61.7%) children with ASD presented blood levels of Vitamin D indicative of a condition of insufficiency (insufficient level 10–30 ng/ml) and 6/47 (12.8%) presented blood levels of Vitamin D indicative of a condition of deficiency (deficient level <10 ng/ml). Just 12/47 (25.5%) subjects presented a level of vitamin D within normal range (normal range 30–100 ng/ml). Mean blood level of vitamin D in children with ASD was 22.7 ng/ml, indicative of a vitamin deficiency. In control group, 24/44 (54.5%) of TD children presented blood levels of Vitamin D indicative of a condition of insufficiency and 1/44 (2.3%) levels indicative of a condition of deficiency. 19/44 (43.2%) of TD subjects presented level of vitamin D in normal range. Mean blood level of vitamin D in TD children was 27.8 ng/ml. Comparing the mean of blood Vitamin D levels, there was a significant difference among the ASD and the TD subjects groups (t = 2.24, p < 0.05). The analysis revealed also a significant difference between age of the two groups. Therefore, a post hoc bootstrap analysis, stratified for the variable age, was performed in order to confirm the significant difference of vitamin D in the two groups. This analysis did not alter the previous result (t = 2.24, p < 0.01). Table 2. Anthropometric parameters and Vitamin D level in ASD vs TD subjects groups. ASD (N = 47) TD (N = 44) Height(cm) ** 104.6 (12.9) 111.3 (16.9) Weight (Kg) ** 18.5 (5.4) 19.9 (8.0) BMI(Kg/m2) ** 16.8 (1.7) * 15.7 (2.0) Vitamin D(ng/ml) ** 22.7 (12.4) * 27.8 (8.4) BMI categories Underweight (<5° percentile) † 2 (4.3) * 6 (13.6) Normal Range (5–85° percentile) † 24 (51.1) * 34 (77.3) Overweight (85–95° percentile) † 15 (31.9) * 4 (9.1) Obese (>95° percentile) † 6 (12.8) * 0 (0.0) Vitamin D level categories Normal (30–100 ng/ml) † 12 (25.5) 19 (43.2) Insufficient (10–30 ng/ml) † 29 (61.7) 24 (54.5) Deficient (<10 ng/ml) † 6 (12.8) 1 (2.3) Note: *p < 0.01; ASD, Autism Spectrum Disorder; TD, Typically-Developing; N., Number; BMI, Body Mass Index; † Expressed as number of patients or controls and percentage in parenthesis; ** Expressed as mean and Standard Deviation in parenthesis. Food habits in children with ASD were detected through KIDMED test to explore adherence to a healthy diet, such as the MD. KIDMED index was used to evaluate adherence to the MD. 12/47 (25.5%) children presented a score ≤3 (low adherence to the MD), 31/44 (66%) presented a score between 4–7 (moderate adherence to the MD) and just 4/47 (8.5%) presented score >8 (high adherence to the MD) (Table 3). To better characterize vitamin D deficiency in children with ASD, a correlation between vitamin D and KIDMED index was assessed but statistical analysis does not show a significant correlation. (Table 4). Severity of clinical features was assessed according to DSM-5 (presence/absence of verbal impairment, presence/absence of intellectual impairment, level of symptoms according to ADOS-2 comparative score (as yet reported in Table 1). A correlation between the indicated variables and blood vitamin D levels in children with ASD was not statistically significant (Table 4). Table 3. MD adherence index of ASD Children (N = 47). KIDMED categories Low adherence † 12 (25.5) Moderate adherence † 31 (66) High adherence † 4 (8.5) Note: MD, Mediterranean Diet; ASD, Autism Spectrum Disorder; N., number; † Expressed as number of patients or controls and percentage in parenthesis. Table 4. Correlation analysis between Vitamin D level, MD adherence and severity of clinical impairment in ASD. Adherence to mediterranean diet Level of severity according DSM-5 Verbal impairment Intellectual impairment ADOS-2 comparative score Coeff. Coeff. Coeff. Coeff. Coeff. Vitamin D 0.081 0.059 −0.127 0.102 0.118 Note: Table shows bivariate correlation analysis between mean serum vitamin D levels in children with ASD and adherence to MD, level of severity (according to DSM-5), verbal impairment, intellectual impairment, ADOS-2 comparative score. Results indicate that correlation between indicated variables and serum vitamin D levels is not statistically significant. Abbreviations: MD, Mediterranean Diet; ASD, Autism Spectrum Disorder; DSM-5, Diagnostic and Statistical Manual of Mental Disorders-5th Edition; ADOS-2, Autism Diagnostic Observation Schedule-2; Coeff., Spearman coefficient of correlation. 4. Discussion Nutrition represents an important factor involved in maintaining an optimal state of health. A useful reference for setting up a correct diet in childhood is the food pyramid, which is inspired by the Mediterranean Diet [20]. The MD guarantees an intake of nutrients, optimal to maintain an adequate nutritional status. We focused our attention on eating habits of a sample of children with ASD, evaluating adherence to the MD, nutritional status, and a possible role of the MD adherence on vitamin D serum level. In the sample, an high percentage of ASD patients had an elevated BMI, which differed significantly from that in a TD subjects group. Moreover, adherence to the MD is low in children with ASD. Our results are in line with literature. In fact, several authors have confirmed that in ASD there is a higher consumption of high energy foods, greater preference for junk food, and lower consumption of healthy foods [21]. These eating habits, also linked to food selectivity, may lead to an increase in body weight up to a “state of obesity”. Therefore, poor feeding seems to be one of the possible reasons to explain the nutritional deficiencies in ASD. The greater incidence of eating problems, particularly food selectivity in ASD, seems to be causedby many factors. For example, sensory difficulties can lead to atypical eating behaviours, whereas children may avoid certain foods due to the consistency and/or taste and eat only a limited variety [7]. Other data underlined the presence of gastrointestinal problems [22], food allergy and intolerance [23] in ASD, suggesting a possible role on feeding and on food choices in this population. However, there is no conclusive answer to this serious issue. Our results show a significant difference between ASD and TD subjects regarding blood level of vitamin D. The ASD group present lower concentrations of vitamin D thanTD children. This data confirms what already reported in literature. Wang T et al. [24] performed a meta-analysis of clinical studies that explored the correlation between vitamin D levels and children with ASD. They reported a serum concentration of vitamin D significantly lower inchildren with ASD in comparison with healthy controls [10],[25]–[32]. This deficiency, together with other risk factors in children with ASD, such as reduced exercise and low exposure to the sun, restrictive diets, calcium deficiency, obesity and use of drugs, cause a low bone mineral density and a greater risk to develop metabolic syndrome and cardiovascular disease. In our sample, low level of vitamin D did not relate with food intake and in particular with adherence to the MD. This data may suggest that the origin of Vitamin D deficiency is not related to food style, despite the inadequate feeding in ASD. Less UVB exposition can led to low synthesis of vitamin D, however children of our sample came from the same geographical area, on the Mediterranean coast, and were regularly exposed to sunlight. It should be taken into account that less endogenous production of vitamin D in ASD might depend by abnormal metabolism pathway possibly due to genetic polymorphisms [33]. Moreover other factors like digestion capacity, absorption, metabolic system, have a significant impact on nutritional status and so could influence vitamin D serum levels. In our samples, children did not present any chronic gastrointestinal disease or other conditions of malabsorption or malnutrition, as those have been considered exclusion criteria for enrollment. However,Vitamin D deficiency in ASD could be linked to insufficient intake derived yet in pregnancy [34], as reported in literature, and to a subsequent capability to replace deficiency during growth in early infant, thought food intake. Gentile et al. [35] suggested a pathogenic model for ASD highlighting the role of an immune dysregulation as primum movens of this disease. Indeed, ASD may result from a complex interaction between genetic predisposition and environmental factors [36]. Among environmental factors, vitamin D may play a critical role because of his well-known effects on modulating immune response. In presence of these two factors (a genetic predisposition and vitamin D deficiency), a viral infection [35],[37] or a reactivation of the mothers can trigger an altered immune response that may lead to pathological neurodevelopment. Experimental evidences have been produced on this topic: gestational vitamin D deficiency has been related to an increase odd of ASD with Intellectual Disability (ID) offspring [38] and with a poorer motor and social development outcome [39]. Interestingly, higher neonatal Vitamin D levels were protective for ASD without ID, raises interesting questions about timing and critical windows to propose vitamin D supplementation [38]. Finally, no difference was observed in relation to the severity of symptoms inASD with or without deficiency of Vitamin D. This data disagrees from other literature results [25],[26],[28], reporting a positive correlation between vitamin D levels and clinical feature. Perhaps, the use of comparative score of ADOS-2 for the evaluation of level and gravity of ASD symptoms, such as the use of intellectual ability and verbal functioning, would indeed confer more effectiveness to the results that we obtained in comparison to other studies in literature which used less structured and reproducible evaluation tools. Our results suggest that low adherence tothe MD may result in a difficulty compensating vitamin D deficiency, so that vitamin D supplementation has to be considered in addition to an balanced diet. It is very important to evaluate this nutritional parameter in regular clinical practice, not only for its posible role on neurodevelopment functions but also for the implications on the general state of health. In literature the experimental use of vitamin D is spreading, reporting an improvement the clinical features in children with ASD [40],[41]. In light of this is important to perform more studies on how the vitamin D may act in the etiopathogenesis and development of ASD and if it can become part of the complementary therapies, given the cost-benefit ratio and the therapeutic security. Nonetheless some limitations catched our attention: a low sample size could have influenced the results observed, although they are in line with previous publications [29],[42]–[44]. ASD group and controls slightly differ for age, nonetheless this difference did not interfere with the results thanks to the bootstrap analysis, afterwards done to avoid statistical bias. Moreover, the data of the eating habits through the 3-day food diary were not presented. Future studies are needed in order to analyze these aspects and carry out a more accurate assessment even for the control group. In conclusion, this study report that children with ASD present low adherence to the MD; this habit might imply overweight and obesity, that are observed in an higher percentage of ASD compared to TD children. Low serum level of vitamin D are confirmed in children with ASD; however, this data does not correlate to adherence to the MD in children with ASD. The authors are grateful to doctors Marco Carifi and Davide De Cristofaro for the english editing and for statistical revision. Conflict of interest: All authors declare no conflicts of interest in this paper. ==== Refs References 1 American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-5®) American Psychiatric Pub 2013 2 Marí-Bauset S Zazpe I Mari-Sanchis A Food selectivity in autism spectrum disorders: a systematic review J Child Neurol 2014 29 1554 1561 24097852 3 Bandini LG Anderson SE Curtin C Food selectivity in children with autism spectrum disorders and typically developing children J Pediatr 2010 157 259 264 20362301 4 Bandini LG Curtin C Phillips S Changes in Food Selectivity in Children with Autism Spectrum Disorder J Autism Dev Disord 2017 47 439 446 27866350 5 Schreck KA Williams K Smith AF A comparison of eating behaviors between children with and without autism J Autism Dev Disord 2004 34 433 438 15449518 6 Schmitt L Heiss CJ Campbell EE A comparison of nutrient intake and eating behaviors of boys with and without autism Top Clin Nutr 2008 23 23 31 7 Riccio MP Franco C Negri R Is food refusal in autistic children related to TAS2R38 genotype? Autism Res 2018 11 531 538 29282878 8 Emond A Emmett P Steer C Feeding symptoms, dietary patterns, and growth in young children with autism spectrum disorders Pediatrics 2010 126 e337 342 20643716 9 Adams JB Audhya T McDonough-Means S Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity Nutr Metab 2011 8 34 10 Meguid NA Hashish AF Anwar M Reduced serum levels of 25-hydroxy and 1, 25-dihydroxy vitamin D in Egyptian children with autism J Altern Complement Med 2010 16 641 645 20569030 11 Di Somma C Scarano E Barrea L Vitamin D and neurological diseases: an endocrine view Int J Mol Sci 2017 18 2482 12 Giustina A Adler RA Binkley N Consensus statement from 2nd International Conference on Controversies in Vitamin D Rev Endocr Metab Disord 2020 21 89 116 32180081 13 Eyles DW Burne TH McGrath JJ Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease Front Neuroendocrinol 2013 34 47 64 22796576 14 Lord C Rutter M DiLavore PC ADOS-2. Autism diagnostic observation schedule Seconda Edizione. Manuale. Edizione italiana 2013 15 Luiz D Barnard A Knoesen N Griffiths mental development scales-extended revised (GMDS-ER) administration manual Amersham (Bucks, UK) Association for Research in Child Development 2004 16 Roid GH Miller LJ Leiter international performance scale-revised (Leiter-R) Wood Dale, IL Stoelting 1997 17 Balboni G Belacchi C Bonichini S Vineland-II. Vineland Adaptive Behavior Scales Second Edition-Survey Form-Standardizzazione italiana 2016 18 Serra-Majem L Ribas L Ngo J Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in children and adolescents Public Health Nutr 2004 7 931 935 15482620 19 Kuczmarski RJ 2000 CDC Growth Charts for the United States: methods and development (No. 246) Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics 2002 20 Keys A Mienotti A Karvonen MJ The diet and 15-year death rate in the seven countries study Am J Epidemiol 1986 124 903 915 3776973 21 Dhaliwal KK Orsso CE Richard C Risk factors for unhealthy weight gain and obesity among children with autism spectrum disorder Int J Mol Sci 2019 20 3285 22 Gabriele S Sacco R Altieri L Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children Autism Res 2016 9 752 759 26437875 23 de Magistris L Picardi A Siniscalco D Antibodies against food antigens in patients with autistic spectrum disorders Biomed Res Int 2013 2013 729349 23984403 24 Wang T Shan L Du L Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis Eur Child Adolesc Psychiatry 2016 25 341 350 26514973 25 Mostafa GA Al-Ayadhi LY Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity J Neuroinflammation 2012 9 201 22898564 26 Gong ZL Luo CM Wang L Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders Neuroreport 2014 25 23 27 24089013 27 Jia F Wang B Shan L Core symptoms of autism improved after vitamin D supplementation Pediatrics 2015 135 e196 198 25511123 28 Saad K Abdel-rahman AA Elserogy YM Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children Nutr Neurosci 2016 19 346 351 25876214 29 Tostes MHFS Polonini HC Gattaz WF Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism Trends Psychiatry Psychother 2012 34 161 163 25923008 30 Neumeyer AM Gates A Ferrone C Bone density in peripubertal boys with autism spectrum disorders J Autism Dev Disord 2013 43 1623 1629 23124396 31 Bener A Khattab AO Al-Dabbagh MM Is high prevalence of Vitamin D deficiency evidence for autism disorder?: In a highly endogamous population J Pediatr Neurosci 2014 9 227 25624924 32 Fernell E Bejerot S Westerlund J Autism spectrum disorder and low vitamin D at birth: a sibling control study Mol Autism 2015 6 3 9 25874075 33 Schmidt RJ Hansen RL Hartiala J Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study Early Hum Dev 2015 91 483 489 26073892 34 Siracusano M Riccioni A Abate R Vitamin D Deficiency and Autism Spectrum Disorder Curr Pharm Des 2020 26 2460 2474 32294031 35 Gentile I Zappulo E Militerni R Etiopathogenesis of autism spectrum disorders: fitting the pieces of the puzzle together Med Hypotheses 2013 81 26 35 23622947 36 Emberti Gialloreti L Mazzone L Benvenuto A Risk and protective environmental factors associated with autism spectrum disorder: evidence-based principles and recommendations J Clin Med 2019 8 217 37 Gentile I Zappulo E Bonavolta R Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders In Vivo 2014 28 667 671 24982239 38 Lee BK Eyles DW Magnusson C Developmental vitamin D and autism spectrum disorders: findings from the Stockholm Youth Cohort Mol Psychiatry 2019 1 11 39 Darling AL Rayman MP Steer CD Association between maternal vitamin D status in pregnancy and neurodevelopmental outcomes in childhood: results from the Avon Longitudinal Study of Parents and Children (ALSPAC) Br J Nutr 2017 117 1682 1692 28697816 40 Feng J Shan L Du L Clinical improvement following vitamin D3 supplementation in autism spectrum disorder Nutr Neurosci 2017 20 284 290 26783092 41 Jia F Shan L Wang B Fluctuations in clinical symptoms with changes in serum 25 (OH) vitamin D levels in autistic children: three cases report Nutr Neurosci 2019 22 863 866 29629638 42 Altun H Kurutaş EB Şahin N The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders Clin Psychopharmacol Neurosci 2018 16 383 390 30466210 43 Arastoo AA Khojastehkia H Rahimi Z Evaluation of serum 25-Hydroxy vitamin D levels in children with autism Spectrum disorder Ital J Pediatr 2018 44 150 30558646 44 Bičíková M Máčová L Ostatníková D Vitamin D in Autistic Children and Healthy Controls Physiol Res 2019 68 317 320 30628824